Back

The polypill in primary and secondary prevention. Where do we stand?

21 October 2022 (16:21 - 16:42)
Organised by: Logo
Seminar Presentation Part of: Prevention strategies in the continuum of CV risk Thrombosis, Bleeding Open Access EuroThrombosis and EuroVessels 2022 WG on Thrombosis

About the speaker

Photo
Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Effects of exercise training on atherothrombotic risk
Professor I. Seljeflot (Oslo, NO)
Presentation thumbnail
Preventive strategies in patients with CKD
Doctor R. Baptista (PT)
Presentation thumbnail
Association between influenza vaccination and cardiovascular diseases
Professor T. Geisler (Tuebingen, DE)

Access the full session

Session thumbnail
Prevention strategies in the continuum of CV risk

The Event

Event poster

EuroThrombosis and EuroVessels 2022

21 October 2022 16:21 CET
You may be interested in
thumbnail
Congress Presentation
Polypill to improve adherence in cardiovascular secondary prevention: a real challenge in real practice
3 September 2019
thumbnail
Congress Presentation
Colchicine for secondary prevention of stroke and other cardiovascular events: a meta-analysis of randomised trials
30 August 2024
thumbnail
Congress Presentation
The CV polypill strategy (acetyl salicylic acid + atorvastatin + ramipril) as baseline treatment after a cardiovascular event supported by recent compelling evidence: a global expert consensus
25 April 2024
thumbnail
Congress Presentation
A survey of availability and affordability of polypills for primary and secondary prevention of cardiovascular diseases in selected countries
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources